| Literature DB >> 30890446 |
Patrick G Rice1, Bhaskar K Somani1, Rowland W Rees2.
Abstract
INTRODUCTION: Plaque incision and grafting (PIG) is indicated for men with complex or severe penile curvature and, despite a multitude of incision types and grafting materials having been used, no individual technique has proven superiority. AIM: To assess outcomes following PIG and to understand the operative technique.Entities:
Keywords: Andrology; Grafting; Penile curvature; Peyronie’s disease; Plaque incision; Review
Year: 2019 PMID: 30890446 PMCID: PMC6523061 DOI: 10.1016/j.esxm.2019.01.001
Source DB: PubMed Journal: Sex Med ISSN: 2050-1161 Impact factor: 2.491
Figure 1Types of incision and resultant defects created.
Baseline characteristics for all studies included in the quantitative synthesis
| Type of graft | Lead author | Study characteristics | Limitations | Patient demographics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | Number of patients | Follow-up, mo, (SD; range) | Country | Study years | Methodological | Noted by authors | Previous operation | Age, y, mean (SD; range) | Onset duration, mo (SD; range) | Degree of curvature (SD; range) | Complex deformity, % (n/N) | Plaque size, cm | ||
| Xenograft | Sayedahmed | 2017 | 43 | 33 (NM; 10–59) | Germany | 2007–2015 | Nonrandomized | No standardized questionnaire for evaluation; no predictive factors for postoperative outcome | NM | 57.4 (NM; 39–82) | sdf 4 | 73.8 (NM; 60–90) | NM | 2.1 (1-4) |
| Cosentino | 2016 | 44 | 19.2 (NM; 11–48) | Spain | 2009–2013 | No IIEF, retrospective, no satisfaction measure, no penile length measurement | – | NM | 56.1 (NM; 49–64) | 24 (MM; 9-48) | >60 in 40 patients | NM | NM | |
| Knoll | 2007 | 162 | 38 (NM; 6–96) | US | 1998–2006 | No IIEF, retrospective, no satisfaction measurement | – | NM | 52 (NM; 33–69) | 16 (NM; 12–30) | 70 (NM; 60–100) | 0 | 1.5 × 4.0–3.0 × 6.0 | |
| Sansalone | 2011 | 157 | 20 (NM; 1224) | Italy/Serbia | 2004–2008 | Retrospective, no penile length measurement | Only 89 patients completed the IIEF. | NM | 55 (±11; 29–70) | sdf 6–12 | NM (NM; NM) | NM | NM | |
| Allograft | Sampaio | 2002 | 40 | NM (NM; 16) | Portugal | 1989–1999 | No IIEF, retrospective, no satisfaction measurement | – | NM | 56 (NM; 43–69) | NM (NM; 24–96) | NM (NM; NM) | NM | 1–7 × 2–2.5 |
| Autograft | Kadioglu | 2018 | 144 | 51.1 (±39.6; NM) | Turkey | 1997–2016 | No IIEF, retrospective, no satisfaction measurement, no penile length measurement | – | NM | 54.1 (±9.2; NM) | 28.2 (±17.3; NM) | 58.4 (±18.9; NM) | 32.5 (37/114) | NM |
| Kalsi | 2005 | 113 | 12 (NM; 8–70) | UK | 1996–2004 | No IIEF, retrospective, no satisfaction measurement | – | 6/113 | 45 (NM; 17–71) | 24 (NM; NM) | 64.5 (NM; 20–180) | 15.9 (18/113) | NM | |
| Montorsi | 2000 | 50 | 32 (NM; 15–54) | Italy | 1995–1998 | No IIEF, retrospective | – | NM | 44 (NM; 28–62) | sdf 6 | 60 (±4; NM) | NM | NM | |
| Akkus | 2001 | 58 | NM | Turkey | 1994–1999 | No IIEF, retrospective, no satisfaction measurement | – | 0/58 | 50 (NM; 39–63) | NM (NM; 12–60) | NM (NM; NM) | NM | NM | |
| El-Sakka | 1998 | 112 | NM | US | 1995–1997 | No IIEF, retrospective | – | NM | 52 (22–73) | sdf 3 | <90 in 82 patients, >90 in 30 patients | 10.7 (12/113) | NM | |
| Multiple | Flores | 2011 | 56 | NM | US | 2002–2004 | Retrospective, no satisfaction measurement, no penile length measurement | No recording of pertinent preoperative characteristics, such as mean preoperative curvature, hemodynamics, and erectile function | NM | 57 (±22; NM) | 22 (±9; NM) | 52 (± 23; NM) | 10.7 (6/56) | 4.7 ± 1.2 cm2 |
| Chung | 2011 | 86 | 98 (NM; 61–120) | Canada | 1995–2005 | Retrospective | Small sample size, patients lost to follow-up, nonrandomized graft material selection, surgery performed across different timelines | 0/86 | 54.6 (NM; 34–73) | 29.1 (NM; 8–60) | 71.7 (NM; 30–160) | NM | NM | |
NM = not mentioned; SD = standard deviation; sdf = stable disease for.
46 contacted for follow-up.
4 had pure hourglass; 4 had concomitant dorsal deformity.
Median.
Waist deformity.
Figure 2Flowchart summarizing databases and article selection process.
Details of grafting materials and techniques used in the 12 studied reviews
| Type of graft | Lead author | Year | Graft material | Incision | Grafting suture material | NVB dissection | Graft size | Additional grafts | Concurrent convex, % (n/N) |
|---|---|---|---|---|---|---|---|---|---|
| Xenograft | Sayedahmed | 2017 | SIS | YY (Egydio) | NM | NM | >20% larger than defect | NM | NM |
| Cosentino | 2016 | SIS | H | 4-0 Vicryl | NM | 6.5 cm2; >0.5 cm larger than defect | NM | NM | |
| Knoll | 2007 | SIS | H | 4-0 polyglycolic acid | NM | 30% larger than defect | NM | NM | |
| Sansalone | 2011 | BPCM | YY (Egydio) | 4-0 poliglecaprone | NM | NM | NM | NM | |
| Allograft | Sampaio | 2002 | HDM | I | NM | NM | 0.5 cm wider, 1 cm longer than defect | NM | NM |
| Autograft | Kadioglu | 2018 | SV | H/YY (Egydio) | 5-0 PDS | Medial | NM | NM | 33.3 (48/144) |
| Kalsi | 2005 | SV | H/I | 3-0 polypropylene/3-0 PDS | Lateral/medial | NM | (30/113 2x)/(5/113 3x) | 38.1 (43/113) | |
| Montorsi | 2000 | SV | H | 5-0 PDS | XXX | NM | (44/50 2x)/(1/50 3x) | 12.0 (6/50) | |
| Akkus | 2001 | SV/DDV | H/I | 4-0 Vicryl/5-0 Vicryl | NM | NM | NM | 24.1 (14/58) | |
| El Sakka | 1998 | SV | H | NM | NM | NM | 12% >1x | 33.0 (37/112) | |
| Multiple | Flores | 2011 | CP (52)/SIS (4) | H/YY (Egydio) | 4-0 PDS | NM | 8 cm2 (SD ±6; range, 4–28) | NM | 0.0 (0/56) |
| Chung | 2011 | D (22)/CP (33)/SIS (33) | NM | NM | NM | 20% larger than defect | NM | NM |
BPCM = bovine pericardium collagen matrix; CP = cadaveric pericardium; D = dermal; DDV = deep dorsal vein; HDM = human dura mater; NM = not mentioned; PDS = polydioxanone; SD = standard deviation; SIS = small intestinal submucosa; SV = saphenous vein.
Histological report available.
Medially in patients with ED or arterial risk factors.
Preoperative, postoperative and change in erectile function with incision and grafting procedures, where recorded
| Type of graft | Lead author | Year | Preoperative | Postoperative | Change | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IIEF score (SD; range) | Erectile status, % (n/N) | IIEF score (SD; range) | Erectile status, % (n/N) | ED change, % (n/N) | ||||||||||
| Unaided | Aided | ED present | Unaided | Aided | Absent | Worsened | Improved | |||||||
| Xenograft | Sayedahmed | 2017 | 16 (±3.5; NM) | NM | NM | NM | 20 (±4.2; NM) | 67.4 (29/43) | 20.9 (9/43) | 11.6 (5/43) | 7.0 (3/43) | 69.8 (30/43) | ↑ | <.001 |
| Cosentino | 2016 | – | 86.7 (39/44) | NM | 11.4 (5/44) | – | 95.5 (42/44) | 4.6 (2/44) | 0.0 (0/44) | 4.6 (2/44) | NM | ↑ | – | |
| Knoll | 2007 | – | NM | NM | 0.0 (0/162) | – | 80.3 (130/162) | 15.4 (25/162) | 4.3 (7/162) | NM | NM | ↓ | – | |
| Sansalone | 2011 | 16 (NM; 15–21) | NM | NM | NM | 22.5 (NM; NM) | 66.9 (105/157) | 33.1 (52/157) | 0.0 (0/157) | NM | NM | ↑ | NM | |
| Allograft | Sampaio | 2002 | – | NM | NM | NM | – | NM | NM | NM | 15.0 (6/40) | NM | ↓ | – |
| Autograft | Kadioglu | 2018 | – | NM | NM | 25.7 (37/144) | – | 66.7 (96/144) | 21.5 (31/144) | 11.8 (17/144) | NM | NM | ↓ | – |
| Kalsi | 2005 | – | 60.2 (68/113) | 39.8 (45/113) | NM | – | 65.5 (74/113) | 11.6 (13/113) | 2.7 (3/113) | 9.7 (11/113) | 3.5 (4/113) | ↓ | – | |
| Montorsi | 2000 | – | NM | NM | 0.0 (0/50) | – | NM | NM | NM | 6.0 (3/50) | 0.0 (0/50) | ↓ | – | |
| Akkus | 2001 | – | NM | NM | 0.0 (0/58) | – | NM | NM | 0.0 (0/58) | 6.9 (4/58) | 0.0 (0/58) | ↓ | – | |
| El Sakka | 1998 | – | NM | NM | 34.8 (39/112) | – | NM | NM | NM | 24.1 (27/112) | 7.1 (8/112) | ↓ | – | |
| Multiple | Flores | 2011 | 23 (±4; NM) | 35.7 (20/56) | 64.3 (36/56) | NM | 17 (±9; NM) | NM | NM | NM | NM | NM | ↓ | <.01 |
| Chung | 2011 | 15.1 (NM; 6–20) | NM | 14.0 (12/86) | NM | 10.8 (NM; 2–15) | NM | 67.4 (31/46) | NM | NM | NM | ↓ | <.01 | |
| – | – | 15.1–23 | 35.7–86.7 | 14.0–64.3 | 0.0–34.8 | 10.8–22.5 | 65.5–95.5 | 4.6–67.4 | 0.0–11.8 | 4.6–24.1 | 0–69.8 | – | – | |
Erectile status absent constitutes erectile function insufficient for sexual intercourse; ↑ indicates overall improvement; ↓, overall worsening.
For the penile rigidity domain, sexual desire and intercourse unchanged (P > .05).
Only 89 patients completed the IIEF.
Recordings of changes in length and penile straightening following incision and grafting procedures
| Type of graft | Lead author | Year | Length change, % (n/N) | Straightening, % (n/N) | |||||
|---|---|---|---|---|---|---|---|---|---|
| Shortening | No change | Lengthening | Straight | Recurrence | Success | Postoperative curvature | |||
| Xenograft | Sayedahmed | 2017 | 27.9 (12/43) | 44.2 (19/43) | 27.9 (12/43) | NM | 14.0 (6/43) | 88.4 (38/43) | <15°: 88.4 (38/43); 15°–30°: 7.0 (3/43); >30°: 4.7 (2/43) |
| Cosentino | 2016 | NM | NM | NM | NM | NM | NM | NM | |
| Knoll | 2007 | 4.9 (8/162) | 46.3 (75/162) | 48.8 (79/162) | NM | 8.6 (14/162) | 91.4 (148/162) | <15°: 91.4 (148/162); >15°: 8.6 (14/162) | |
| Sansalone | 2011 | NM | NM | NM | 87.9 (138/157) | NM | 87.9 (138/157) | <15°: 12.1 (19/157) | |
| Allograft | Sampaio | 2002 | NM | 95.0 (38/40) | 5.0 (2/40) | NM | 2.5 (1/40) | NM | NM |
| Autograft | Kadioglu | 2018 | NM | NM | NM | NM | 13.9 (20/144) | 87.5 (126/144) | 0°–20°: 87.5 (126/144) |
| Kalsi | 2005 | 25.7 (29/113) | NM | NM | NM | NM | 85.8 (97/113) | <10°: 85.8 (97/113); 10°–30°: 10.6 (12/113); >30°: 3.3 (4/113) | |
| Montorsi | 2000 | 40.0 (20/50) | 60.0 (30/50) | NM | 80.0 (40/50) | 6.0 (3/50) | 80.0 (40/50) | <30°: 14 (7/50); >30°: 6 (3/50) | |
| Akkus | 2001 | 22.4 (13/58) | 77.6 (45/58) | NM | 86.2 (50/58) | 1.7 (1/58) | 86.2 (50/58) | <30°: 12.1 (7/58); >30°: 5.2 (3/58) | |
| El Sakka | 1998 | 17.0 (19/112) | 73.2 (82/112) | 9.8 (11/112) | 96.4 (108/112) | 4.5 (5/112) | 96.4 (108/112) | NM | |
| Multiple | Flores | 2011 | NM | NM | NM | NM | NM | NM | NM |
| Chung | 2011 | 21.7 (10/46) | NM | NM | NM | 78.3 (36/46) | NM | NM | |
| Range | – | – | 4.9–40.0 | 44.2–95.0 | 5.0-48.8 | 80.0–96.4 | 1.7–78.3 | 80.0–96.4 | – |
Straight, defined by the subjective reporting of the penis being straight with no measurement or range of measurements given.
No statistically significant difference in length.
%/N not given, 2.5 cm median gain (range, 1.5–3.5 cm).
Minimal recurrence.
Complications following incision and grafting procedures, where recorded
| Type of graft | Lead author | Year | Satisfaction, % (n/N) | Reoperation, % (n/N) | Complications, % (n/N) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Altered sensation | Recovery from altered sensation | Hematoma | Pain | Edema | Infection | |||||
| Xenograft | Sayedahmed | 2017 | 86.0 (37/43) | 4.7 (2/43) | 9.3 (4/43) | NM | NM | 7.0 (3/43) | NM | 0.0 (0/43) |
| Cosentino | 2016 | NM | NM | NM | NM | NM | 6.8 (3/44) | 11.4 (5/44) | 2.3 (1/44) | |
| Knoll | 2007 | NM | 4.3 (7/162) | 16.7 (27/162) | 100.0 (27/27) | 1.9 (3/162) | 0.0 (0/162) | NM | 0.0 (0/162) | |
| Sansalone | 2011 | 97 | NM | 3.2 (5/157) | NM | NM | NM | NM | NM | |
| Allograft | Sampaio | 2002 | NM | NM | 22.5 (9/40) | 88.9 (8/9) | 0.0 (0/40) | NM | 20.0 (8/40) | NM |
| Autograft | Kadioglu | 2018 | NM | 0.7 (1/144) | NM | NM | NM | NM | NM | NM |
| Kalsi | 2005 | NM | 0.9 (1/113) | 8.8 (10/113) | 80.0 (8/10) | 0.9 (1/113) | 2.7 (3/113) | NM | NM | |
| Montorsi | 2000 | 88.0 (44/50) | NM | 2.0 (1/50) | NM | 4.0 (2/50) | NM | NM | 2.0 (1/50) | |
| Akkus | 2001 | NM | NM | NM | 100 | NM | NM | NM | NM | |
| El Sakka | 1998 | 92.0 (103/112) | NM | 9.8 (11/112) | NM | NM | NM | 2.7 (3/112) | 2.7 (3/112) | |
| Multiple | Flores | 2011 | NM | NM | 16.1 (9/56) | 100.0 (9/9) | NM | NM | NM | NM |
| Chung | 2011 | <35 | NM | 13.0 (6/46) | NM | NM | NM | NM | NM | |
| Range | – | – | 88.0–92.0 | 0.7–4.7 | 2.0–22.5 | 80.0–100.0 | 0.0–4.0 | 0.0–7.0 | 0.0–20.0 | 0.0–2.7 |
Sansalone et al and Chung et al excluded from range.
Success 75.0% (108/144).
Of partners.
>65% dissatisfied.
Success 92.9% (105/113).
No total value given.